Midazolam is used to calm patients before medical procedures and surgeries, and to help control seizures. It works by slowing down brain activity to reduce anxiety and help people relax or fall asleep.[2] Versed is currently approved and in use across 138 indications[4].[1]
Versed is one of 2288 small molecule programs targeting Glioma. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
2828 competitors in Breast Cancer
Versed
Tykerb
Nolvadex
Zolymbus
Methylthioninium Chloride
Zinecard
Feraheme
Cortef
Systemic Therapy
Apatinib Mesylate
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
May 26, 1987
VERSED
NDA NDA018654
Oct 15, 1998
VERSED
NDA NDA020942
Sep 14, 2018
SEIZALAM
NDA NDA209566
May 17, 2019
NAYZILAM
NDA NDA211321
Mar 22, 2021
MIDAZOLAM IN 0.9% SODIUM CHLORIDE
NDA NDA211844
Jul 20, 2022
MIDAZOLAM IN 0.8% SODIUM CHLORIDE
NDA NDA215868
Aug 8, 2022
MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
NDA NDA216359
Sources
Details